论文部分内容阅读
目的对化疗联合复方皂矾丸在治疗中晚期原发性肝癌患者的效果进行研究。方法 61例中晚期原发性肝癌患者作为此次探究分析对象,并按照随机分配的原则将患者分为观察组(31例)与对照组(30例)。对照组单纯应用化疗治疗,观察组在对照组基础上应用复方皂矾丸进行联合治疗,比较分析两组的临床疗效及不良反应发生率。结果对照组治疗总有效率(20.00%)显著低于观察组(64.52%),差异有统计学意义(P<0.05)。对照组不良反应发生率(56.67%)显著高于观察组(25.81%),差异有统计学意义(P<0.05)。结论给予中晚期原发性肝癌患者应用复方皂矾丸联合化疗的方案进行治疗,可取得较为显著的临床疗效,安全可靠,值得临床大力推广并广泛应用。
Objective To study the effect of combined chemotherapy and soap group on the treatment of patients with primary liver cancer in the advanced stage. Methods Sixty-one patients with advanced primary liver cancer were enrolled in this study. According to the principle of random assignment, patients were divided into observation group (31 cases) and control group (30 cases). The control group was treated with chemotherapy alone. The observation group was treated with compound Zaofan Pills on the basis of the control group, and the clinical efficacy and the incidence of adverse reactions were compared between the two groups. Results The total effective rate (20.00%) in the control group was significantly lower than that in the observation group (64.52%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the control group (56.67%) was significantly higher than that in the observation group (25.81%), the difference was statistically significant (P <0.05). Conclusions The application of compound Zaofan pills in combination with chemotherapy for the treatment of patients with primary liver cancer in the middle and late stages can achieve more significant clinical effects and is safe and reliable. It is worthy of clinical promotion and widespread application.